Bioven   Report issue

For profit Phase 2 Phase 3
Founded: Kuala Lumpur Malaysia (2002)

Organization Overview

First Clinical Trial
2007
NCT00516685
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Bioven Europe | Bioven (Europe) Limited | Bioven Sdn. Bhd.